SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

Corvus Pharmaceuticals to participate in Cantor Global Healthcare conference

Corvus Pharmaceuticals said its leadership team will hold one-on-one investor meetings and take part in a fireside chat at the 2026 Cantor Global Healthcare Conference.

CRVS

SOUTH SAN FRANCISCO, Calif., Sept.

03, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS, a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and participate in a fireside chat presentation a…